Search Results - "tyrosine kinase"

Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents by Rania S.M. Ismail, Nasser S.M. Ismail, Sahar Abuserii, Dalal A. Abou El Ella

Connect to this object online.

: A Novel ROS1 Oncogenic Fusion Detected on Next Generation Sequencing by Anurag Mehta, Himanshi Diwan, Shrinidhi Nathany, Ullas Batra, Manoj Gupta, Manoj Kumar Panigrahi, Dushyant Kumar, Sakshi Mattoo, Aayushi Singh

Connect to this object online.

Impact of dermatologic adverse reactions on QOL in oncologic patients: results from a single-center prospective study by Barbu Maria Alexandra, Niţipir Cornelia, Voiosu Theodor, Giurcăneanu Călin

Connect to this object online.

New Strategies and In Vivo Monitoring Methods for Stem Cell-Based Anticancer Therapies by Ping Wang, Aitor Aguirre

Connect to this object online.

Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali,... by Widiasari Ni Putu Ayu, Rai Ida Bagus Ngurah, Dwi Kusumawardani Ida Ayu Jasminarti, Sajinadiyasa I Gede Ketut, Candrawati Ni Wayan, Arisanti Ni Luh Putu Eka

Connect to this object online.

CNS-invasive aspergillosis following ibrutinib therapy by Matthew Kurian, Eric Vick, Dipen Khanapara

Connect to this object online.

Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study by Abe M, Tsushima K, Sakayori M, Suzuki K, Ikari J, Terada J, Tatsumi K

Connect to this object online.

TKI or TKI combined with PD-1 inhibitors as second-line treatment for HCC patients after sorafenib failure by Jin Lei, Bowen Chen, Meiru Song, Linzhi Zhang, Xinfeng Zhang, Xiaoqiang Gao, Yinyin Li, Yinying Lu, Yinying Lu, Yinying Lu, Shi Zuo, Shi Zuo

Connect to this object online.

Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib by Pantazi D, Ntemou N, Brentas A, Alivertis D, Skobridis K, Tselepis AD

Connect to this object online.

Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study by Caiyun Nie, Caiyun Nie, Caiyun Nie, Caiyun Nie, Weifeng Xu, Weifeng Xu, Weifeng Xu, Weifeng Xu, Huifang Lv, Huifang Lv, Huifang Lv, Huifang Lv, Xiaohui Gao, Guofeng Li, Beibei Chen, Beibei Chen, Beibei Chen, Beibei Chen, Jianzheng Wang, Jianzheng Wang, Jianzheng Wang, Jianzheng Wang, Yingjun Liu, Jing Zhao, Jing Zhao, Jing Zhao, Jing Zhao, Yunduan He, Yunduan He, Yunduan He, Yunduan He, Saiqi Wang, Saiqi Wang, Saiqi Wang, Saiqi Wang, Xiaobing Chen, Xiaobing Chen, Xiaobing Chen, Xiaobing Chen

Connect to this object online.

Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy by Francesca Lazzara, Federica Conti, Pradip K. Sasmal, Shanavas Alikunju, Settimio Rossi, Filippo Drago, Filippo Drago, Chiara Bianca Maria Platania, Chiara Bianca Maria Platania, Claudio Bucolo, Claudio Bucolo

Connect to this object online.

Edaravone Alleviated Propofol-Induced Neurotoxicity in Developing Hippocampus by mBDNF/TrkB/PI3K Pathway by Yang Y, Yi J, Pan M, Hu B, Duan H

Connect to this object online.

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example by Rui Xiong, Jing Lei, Lu Wang, Shipeng Zhang, Hengxu Liu, Hongping Wang, Tao Liu, Xiaodan Lai

Connect to this object online.

Pharmacodynamic Response to Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in a Global, Phase 2, Randomized, Double-Blind, Placebo-Controlled Psoriasis Trial by Ian M. Catlett, Lu Gao, Yanhua Hu, Subhashis Banerjee, James G. Krueger

Connect to this object online.

Disorders of FZ-CRD; insights towards FZ-CRD folding and therapeutic landscape by Reham M. Milhem, Bassam R. Ali

Connect to this object online.

Anti-PD-1/L1 antibody plus anti-VEGF antibody vs. plus VEGFR-targeted TKI as first-line therapy for unresectable hepatocellular carcinoma: a network meta-analysis by Yiwen Zhou, Jingjing Li, Jieer Ying

Connect to this object online.

Discovery of 1<i>H</i>-benzo[<i>d</i>]imidazole-(halogenated) Benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors by Tebyan O. Mirgany, Hanadi H. Asiri, A. F. M. Motiur Rahman, Mohammed M. Alanazi

Connect to this object online.

A rapid and convenient method for synthesis of anilinoquinazoline: an improved synthesis of erlotinib derivatives by Zahra Haghighijoo, Zahra Rezaei, SamanehTaheri, Meisam Jani, Soghra Khabnadideh

Connect to this object online.

Spontaneous Iliopsoas Muscle Hemorrhage Secondary to Ibrutinib (Imbruvica; Pharmacyclics) by Anna Sarcon MD, Gregory P. Botta MD, PhD, Nikunj Patel MD, Alan Saven MD

Connect to this object online.

Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature by Bader Alharbi, Samer Alamri, Ahmed Mahdi, Siham Marghalani

Connect to this object online.